Detalhe da pesquisa
1.
Epidemiology and clinical outcomes of light-chain amyloidosis in Sweden: A nationwide population-based study.
Eur J Haematol
; 111(5): 697-705, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533343
2.
Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial.
BMC Cancer
; 22(1): 147, 2022 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123422
3.
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group.
Lancet Oncol
; 22(3): e105-e118, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33662288
4.
Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long-term survival follow-up from the Phase II study O-12-M1.
Br J Haematol
; 193(6): 1105-1109, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403663
5.
Autoimmune disease is associated with a lower risk of progression in monoclonal gammopathy of undetermined significance.
Eur J Haematol
; 106(3): 380-388, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33295006
6.
Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study.
Haematologica
; 105(6): 1650-1659, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515355
7.
Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry.
Eur J Haematol
; 104(5): 376-382, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31733147
8.
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.
Blood
; 127(9): 1109-16, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26802176
9.
Outcome and survival of myeloma patients diagnosed 2008-2015. Real-world data on 4904 patients from the Swedish Myeloma Registry.
Haematologica
; 103(3): 506-513, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217784
10.
New prognostic tools for myeloma.
Blood
; 125(13): 2014-5, 2015 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25814486
11.
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register.
Eur J Haematol
; 99(3): 216-222, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28544116
12.
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial.
Blood
; 121(23): 4647-54, 2013 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23616624
13.
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients.
Haematologica
; 100(1): 107-13, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25344526
14.
Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial.
Haematologica
; 105(12): 2879-2882, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256392
15.
Improved survival in myeloma patients: starting to close in on the gap between elderly patients and a matched normal population.
Br J Haematol
; 164(5): 684-93, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24313224
16.
Effectiveness and infectious complications of BCMA T-cell engagers in treating multiple myeloma: Real-world evidence from Sweden.
Cancer Med
; 13(8): e7048, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38651177
17.
Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study.
Blood
; 118(24): 6284-91, 2011 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-21998210
18.
A combination regimen of bortezomib, cyclophosphamide and betamethasone gives quicker, better and more durable response than VAD/CyBet regimens: results from a Swedish retrospective analysis.
Acta Haematol
; 130(1): 7-15, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23363691
19.
Patient Confidence and Information Preferences During the Treatment Decision-making Process: Results From a Large Multiple Myeloma Patient Survey Across 12 Countries in Europe and Israel.
Clin Lymphoma Myeloma Leuk
; 23(5): e240-e251.e12, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967243
20.
European perspective on multiple myeloma treatment strategies: update following recent congresses.
Oncologist
; 17(5): 592-606, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22573721